Regulatory panel clears Serum Institute's vaccine candidate 'Covishield' for emergency use

Regulatory panel clears Serum Institute’s vaccine candidate ‘Covishield’ for emergency use

Subject Expert Committee (SEC) granted Emergency Use Authorization (EUA) for Covishield

A final application will be sent to DCGI before the rollout

Bharat Biotech developed the vaccine in collaboration with ICMR

A national expert panel has suggested vaccinating 30 crore people in the first half of 2021

Share.

Comments are closed.

Get to know the
Exclusively Curated by Channeliam
Top Startups
channeliam.com
Get to know the
Exclusively Curated by Channeliam
Top Startups
channeliam.com
Exit mobile version